On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products springing from a number of reports that people using the products were developing serious liver issues and other health worries. Less than seven days later, on May four, the first Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Settlements alleges company neglectfulness in informing the public about potential hazards of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.

A class action legal action is filed by a group of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less expensive, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there is a settlement. At that time, the lawyer who handled the suit will take his costs from the compensation that was awarded and then distribute the remaining funds to the plaintiffs in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action lawsuits have become so popular.

The initial class action legal action against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall took place in the U. S. where twenty-three cases of liver disorders and other health issues had been reported. Health Canada failed to receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning folks who sustained respiration, neurological, cardio, and stomach problems as a consequence of Canadians using the products.

The Hydroxycut Lawsuits alleges that the products without correctly informing the products without properly informing the public of the health risks that they could exposing patrons to. The complaint states the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological issues. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled buyers concerning the security of the products.